3D Systems Creates Systemic Bio, a Biotech Company for Drug Discovery and Development with Bioprinting
ROCK HILL, SC, USA, Sep 13, 2022 – 3D Systems (NYSE:DDD) announced the formation of a new, wholly owned company called Systemic Bio, a biotech company focused on the application of advanced bioprinting technologies to pharmaceutical drug discovery and development. Systemic Bio will leverage 3D Systems’ breakthrough, production-level bioprinting technology to create extremely precise vascularized organ models using biomaterials and human […]
2022-09-14 22:04